Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?

被引：0
|
作者：
Susanne Beckebaum
Vito R. Cicinnati
机构：
[1] University Hospital Essen,Department of Gastroenterology and Hepatology
[2] University of Duisburg-Essen,Department of General, Visceral and Transplantation Surgery
[3] University Hospital Essen,undefined
[4] University of Duisburg-Essen,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：2
相关论文
共 50 条
  • [21] A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction.
    Day, CP
    O'Grady, J
    Mayer, D
    Simpson, K
    Millson, CE
    Solomons, N
    Duncan, J
    Bechter, M
    Patch, D
    HEPATOLOGY, 2004, 40 (04) : 547A - 547A
  • [22] Impact of combined mycophenolate mofetil and low dose calcineurin inhibitor therapy on T cell function.
    Cicinnati, Vito R.
    Yu, Zhengya
    Klein, Christian G.
    Frilling, Andrea
    Gerken, Guido
    Broelsch, Christoph E.
    Beckebaum, Susanne
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 340 - 340
  • [23] Long-lasting improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil
    Boyer, O.
    Iserin, F.
    Dechaux, M.
    Gubler, M. C.
    Salomon, R.
    Niaudet, P.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1447 - 1447
  • [24] Use of mycophenolate mofetil with/without low-dose calcineurin inhibitor for recipients with impaired renal function after living donor liver transplantation
    Kim, K
    Lee, S
    Park, K
    Hwang, S
    Kim, K
    Ahn, C
    Moon, D
    Ha, T
    Cho, S
    Oh, K
    Kim, Y
    LIVER TRANSPLANTATION, 2004, 10 (06) : C23 - C23
  • [25] Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients.
    Lin, Kuo Jen
    Wang, Hsu-Han
    Lin, Chih-Te
    Pan, Pai-Yen
    Chen, Sy-Yuan
    TRANSPLANTATION, 2024, 108 (09) : 592 - 592
  • [26] Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens
    Dubay, Derek
    Smith, Rob J.
    Qiu, Kenneth G.
    Levy, Gary A.
    Lilly, Leslie
    Therapondos, George
    LIVER TRANSPLANTATION, 2008, 14 (05) : 651 - 659
  • [27] Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
    Barkmann, A
    Nashan, B
    Schmidt, HHJ
    Böker, KHW
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Hoffmann, MW
    Manns, MP
    Klempnauer, J
    Schlitt, HJ
    TRANSPLANTATION, 2000, 69 (09) : 1886 - 1890
  • [28] Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil
    Pascual, J
    Quereda, C
    Zamora, J
    Hernández, D
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3746 - 3748
  • [29] Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction:: a randomised controlled study
    Schlitt, HJ
    Barkmann, A
    Böker, KHW
    Schmidt, HHJ
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Tusch, G
    Manns, MP
    Nashan, B
    Klempnauer, J
    LANCET, 2001, 357 (9256): : 587 - 591
  • [30] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
12345